Results 21 to 30 of about 9,113,589 (351)
Multicentric Cutaneous Crohn's Disease: A Case Report and Review of Literature
A patient presented with skin lesions at sites not contiguous with Crohn's disease of the bowel and with specific histological features of Crohn's disease occurring two weeks from the onset of bowel symptoms.
Robert Prokopetz+3 more
doaj +1 more source
Infliximab maintenance therapy for fistulizing Crohn's disease.
BACKGROUND Infliximab, a monoclonal antibody against tumor necrosis factor, is an effective maintenance therapy for patients with Crohn's disease without fistulas.
B. Sands+17 more
semanticscholar +1 more source
Adenocarcinoma arising from chronic perianal crohn's disease: a case report
Malignant transformation of perineal fistula in Crohn's disease has rarely been reported. We report a case of Crohn's disease with recurrent perineal fistulas.
Hanane Massit+5 more
doaj +1 more source
Key Clinical Message To date, the pathogenic mechanisms of the association between Crohn's disease and MALT lymphoma are ambiguous and yet remain to be elucidated.
Amira Hmidi+4 more
doaj +1 more source
Introduction Crohn's disease is a chronic inflammatory bowel disease of unknown etiology which may affect any part of the bowel. Fistulas are a common and often serious complication of Crohn's disease. The treatment for fistulizing Crohn's disease can be
Simopoulos Konstantinos+7 more
doaj +1 more source
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
BACKGROUND Treatment with infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, can result in the formation of antibodies against infliximab.
F. Baert+6 more
semanticscholar +1 more source
The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update.
OBJECTIVE We aimed to provide an evidence-supported update of the ECCO-ESPGHAN guideline on the medical management of paediatric Crohn's disease [CD]. METHODS We formed 10 working groups and formulated 17 PICO-structured clinical questions [Patients ...
P. V. van Rheenen+24 more
semanticscholar +1 more source
Esophageal Crohn's Disease Treated “Topically” with Swallowed Aerosolized Budesonide
Proximal Crohn's disease, involving the esophagus, the stomach, the duodenum, and the proximal jejunum, is uncommon. Treatment for proximal Crohn's disease is based on data derived from case series than from controlled trials.
Petros Zezos+4 more
doaj +1 more source
Uveitis as first manifestation of probably Crohn's disease
Extraintestinal manifestations of Crohn's disease are common. Although ocular complications of Crohn's disease are infrequent, most ocular manifestations include iritis, uveitis, episcleritis, scleritis and conjuntivitis.
Ieda Maria Alexandre Barreira+4 more
doaj +1 more source
Infliximab for the treatment of fistulas in patients with Crohn's disease.
BACKGROUND Enterocutaneous fistulas are a serious complication of Crohn's disease and are difficult to treat. Infliximab, a chimeric monoclonal antibody to tumor necrosis factor alpha, has recently been developed as a treatment for Crohn's disease.
Tephan+18 more
semanticscholar +1 more source